Nanostructured Lipid Carriers for Enhanced Transscleral Delivery of Dexamethasone Acetate: Development, Ex Vivo Characterization and Multiphoton Microscopy Studies
- PMID: 36839729
- PMCID: PMC9961953
- DOI: 10.3390/pharmaceutics15020407
Nanostructured Lipid Carriers for Enhanced Transscleral Delivery of Dexamethasone Acetate: Development, Ex Vivo Characterization and Multiphoton Microscopy Studies
Abstract
Corticosteroids, although highly effective for the treatment of both anterior and posterior ocular segment inflammation, still nowadays struggle for effective drug delivery due to their poor solubilization capabilities in water. This research work aims to develop nanostructured lipid carriers (NLC) intended for periocular administration of dexamethasone acetate to the posterior segment of the eye. Pre-formulation studies were initially performed to find solid and liquid lipid mixtures for dexamethasone acetate solubilization. Pseudoternary diagrams at 65 °C were constructed to select the best surfactant based on the macroscopic transparency and microscopic isotropy of the systems. The resulting NLC, obtained following an organic solvent-free methodology, was composed of triacetin, Imwitor® 491 (glycerol monostearate >90%) and tyloxapol with Z-average = 106.9 ± 1.2 nm, PDI = 0.104 ± 0.019 and zeta potential = -6.51 ± 0.575 mV. Ex vivo porcine sclera and choroid permeation studies revealed a considerable metabolism in the sclera of dexamethasone acetate into free dexamethasone, which demonstrated higher permeation capabilities across both tissues. In addition, the NLC behavior once applied onto the sclera was further studied by means of multiphoton microscopy by loading the NLC with the fluorescent probe Nile red.
Keywords: NLC; dexamethasone; dexamethasone acetate; ex vivo; multiphoton microscopy; ocular delivery; posterior segment; tyloxapol.
Conflict of interest statement
The authors declare no conflict of interest. Felipe M. González-Fernández and Paolo Gasco are from Nanovector S.r.l.: the company had no role in the design of the study; in the collection, analysis, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures










Similar articles
-
A Full Factorial Design to Optimize Aminexil Nano Lipid Formulation to Improve Skin Permeation and Efficacy Against Alopecia.AAPS PharmSciTech. 2023 Jan 18;24(1):40. doi: 10.1208/s12249-023-02500-3. AAPS PharmSciTech. 2023. PMID: 36653508
-
Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.Artif Cells Nanomed Biotechnol. 2018;46(sup1):15-31. doi: 10.1080/21691401.2017.1408124. Epub 2017 Nov 28. Artif Cells Nanomed Biotechnol. 2018. PMID: 29183147
-
Topical Nanostructured Lipid Carrier Based Hydrogel of Mometasone Furoate for the Treatment of Psoriasis.Pharm Nanotechnol. 2018;6(2):133-143. doi: 10.2174/2211738506666180523112513. Pharm Nanotechnol. 2018. PMID: 29788899
-
Cutting-edge advances in therapy for the posterior segment of the eye: Solid lipid nanoparticles and nanostructured lipid carriers.Int J Pharm. 2020 Nov 15;589:119831. doi: 10.1016/j.ijpharm.2020.119831. Epub 2020 Sep 1. Int J Pharm. 2020. PMID: 32877729 Review.
-
Lipid Nanoparticles for the Posterior Eye Segment.Pharmaceutics. 2021 Dec 31;14(1):90. doi: 10.3390/pharmaceutics14010090. Pharmaceutics. 2021. PMID: 35056986 Free PMC article. Review.
Cited by
-
Combined Therapy of Experimental Autoimmune Uveitis by a Dual-Drug Nanocomposite Formulation with Berberine and Dexamethasone.Int J Nanomedicine. 2023 Jul 31;18:4347-4363. doi: 10.2147/IJN.S417750. eCollection 2023. Int J Nanomedicine. 2023. PMID: 37545873 Free PMC article.
-
Recent Progress of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Ocular Drug Delivery Platforms.Pharmaceuticals (Basel). 2023 Mar 22;16(3):474. doi: 10.3390/ph16030474. Pharmaceuticals (Basel). 2023. PMID: 36986574 Free PMC article. Review.
-
3D-printed setup for ocular drug delivery evaluation on ex vivo porcine whole eye.Sci Rep. 2025 Jul 31;15(1):27966. doi: 10.1038/s41598-025-12081-9. Sci Rep. 2025. PMID: 40744966 Free PMC article.
-
Natural-Origin Betaine Surfactants as Promising Components for the Stabilization of Lipid Carriers.Int J Mol Sci. 2024 Jan 12;25(2):955. doi: 10.3390/ijms25020955. Int J Mol Sci. 2024. PMID: 38256029 Free PMC article.
-
Recent Achievements and Perspectives in Smart Nano-in-Micro Platforms for Ocular Disease Treatment.Int J Nanomedicine. 2025 Jun 17;20:7579-7612. doi: 10.2147/IJN.S518643. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40546796 Free PMC article. Review.
References
-
- Gaballa S.A., Kompella U.B., Elgarhy O., Alqahtani A.M., Pierscionek B., Alany R.G., Abdelkader H. Corticosteroids in ophthalmology: Drug delivery innovations, pharmacology, clinical applications, and future perspectives. Drug Deliv. Transl. Res. 2021;11:866–893. doi: 10.1007/s13346-020-00843-z. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources